Sacha Reichman

Dr. Sacha Reichman

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cell
Verified
Journal Article
Closed access
NANajate Aït-Ali
Najate Aït-Ali
RFRam Fridlich
Ram Fridlich
GMGéraldine Millet-Puel
Géraldine Millet-Puel
ECEmmanuelle Clérin
Emmanuelle Clérin
FDFrançois Delalande
François Delalande
Thierry LéveillardThierry Léveillard
Thierry Léveillard

20 February 2017 in Stem Cells
Verified
Journal Article
Open access
PDF file
SRSacha Reichman
Sacha Reichman
ASAmélie Slembrouck
Amélie Slembrouck
GGGiuliana Gagliardi
Giuliana Gagliardi
ACAntoine Chaffiol
Antoine Chaffiol
ATAngélique Terray
Angélique Terray
OGOlivier Goureau
Olivier Goureau
Human induced pluripotent stem cells (hiPSCs) are potentially useful in regenerative therapies for retinal disease. For medical applications, therapeutic retinal cells, such as retinal pigmented epithelial (RPE) cells or photoreceptor precursors, must be generated under completely defined conditions. To this purpose, we have developed a two-step xeno-free/feeder-free (XF/FF) culture system to efficiently differentiate hiPSCs into retinal cells. This simple method, relies only on adherent hiPSCs cultured in chemically defined media, bypassing embryoid body formation. In less than 1 month, adherent hiPSCs are able to generate self-forming neuroretinal-like structures containing retinal progenitor cells (RPCs). Floating cultures of isolated structures enabled the differentiation of RPCs into all types of retinal cells in a sequential overlapping order, with the generation of transplantation-compatible CD73+ photoreceptor precursors in less than 100 days. Our XF/FF culture conditions allow the maintenance of both mature cones and rods in retinal organoids until 280 days with specific photoreceptor ultrastructures. Moreover, both hiPSC-derived retinal organoids and dissociated retinal cells can be easily cryopreserved while retaining their phenotypic characteristics and the preservation of CD73+ photoreceptor precursors. Concomitantly to neural retina, this process allows the generation of RPE cells that can be effortlessly amplified, passaged, and frozen while retaining a proper RPE phenotype. These results demonstrate that simple and efficient retinal differentiation of adherent hiPSCs can be accomplished in XF/FF conditions. This new method is amenable to the development of an in vitro GMP-compliant retinal cell manufacturing protocol allowing large-scale production and banking of hiPSC-derived retinal cells and tissues.

17 August 2020 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
JSJules Scholler
Jules Scholler
KGKassandra Groux
Kassandra Groux
OGOlivier Goureau
Olivier Goureau
JSJosé-Alain Sahel
José-Alain Sahel
MFMathias Fink
Mathias Fink
KGKate Grieve
Kate Grieve
Optical coherence tomography offers astounding opportunities to image the complex structure of living tissue but lacks functional information. We present dynamic full-field optical coherence tomography as a technique to noninvasively image living human induced pluripotent stem cell-derived retinal organoids. Coloured images with an endogenous contrast linked to organelle motility are generated, with submicrometre spatial resolution and millisecond temporal resolution, creating a way to identify specific cell types in living tissue via their function.

25 January 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
HKHanen Khabou
Hanen Khabou
Marcela Garita-HernandezMarcela Garita-Hernandez
Marcela Garita-Hernandez
ACAntoine Chaffiol
Antoine Chaffiol
SRSacha Reichman
Sacha Reichman
CJCéline Jaillard
Céline Jaillard
DDDeniz Dalkara
Deniz Dalkara
Intraocular injection of adeno-associated viral (AAV) vectors has been an evident route for delivering gene drugs into the retina. However, gaps in our understanding of AAV transduction patterns within the anatomically unique environments of the subretinal and intravitreal space of the primate eye impeded the establishment of noninvasive and efficient gene delivery to foveal cones in the clinic. Here, we establish new vector-promoter combinations to overcome the limitations associated with AAV-mediated cone transduction in the fovea with supporting studies in mouse models, human induced pluripotent stem cell–derived organoids, postmortem human retinal explants, and living macaques. We show that an AAV9 variant provides efficient foveal cone transduction when injected into the subretinal space several millimeters away from the fovea, without detaching this delicate region. An engineered AAV2 variant provides gene delivery to foveal cones with a well-tolerated dose administered intravitreally. Both delivery modalities rely on a cone-specific promoter and result in high-level transgene expression compatible with optogenetic vision restoration. The model systems described here provide insight into the behavior of AAV vectors across species to obtain safety and efficacy needed for gene therapy in neurodegenerative disorders.

4 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Marcela Garita-HernandezMarcela Garita-Hernandez
Marcela Garita-Hernandez
MLMaruša Lampič
Maruša Lampič
ACAntoine Chaffiol
Antoine Chaffiol
LGLaure Guibbal
Laure Guibbal
FRFiona Routet
Fiona Routet
JDJens Duebel
Jens Duebel
A major challenge in the treatment of retinal degenerative diseases, with the transplantation of replacement photoreceptors, is the difficulty in inducing the grafted cells to grow and maintain light sensitive outer segments in the host retina, which depends on proper interaction with the underlying retinal pigment epithelium (RPE). Here, for an RPE-independent treatment approach, we introduce a hyperpolarizing microbial opsin into photoreceptor precursors from newborn mice, and transplant them into blind mice lacking the photoreceptor layer. These optogenetically-transformed photoreceptors are light responsive and their transplantation leads to the recovery of visual function, as shown by ganglion cell recordings and behavioral tests. Subsequently, we generate cone photoreceptors from human induced pluripotent stem cells, expressing the chloride pump Jaws. After transplantation into blind mice, we observe light-driven responses at the photoreceptor and ganglion cell levels. These results demonstrate that structural and functional retinal repair is possible by combining stem cell therapy and optogenetics.

22 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJing Liu
Jing Liu
DODaniela Ottaviani
Daniela Ottaviani
MSMeriem Sefta
Meriem Sefta
CDCéline Desbrousses
Céline Desbrousses
ECElodie Chapeaublanc
Elodie Chapeaublanc
FRFrancois Radvanyi
Francois Radvanyi
Retinoblastoma is the most frequent intraocular malignancy in children, originating from a maturing cone precursor in the developing retina. Little is known on the molecular basis underlying the biological and clinical behavior of this cancer. Here, using multi-omics data, we demonstrate the existence of two retinoblastoma subtypes. Subtype 1, of earlier onset, includes most of the heritable forms. It harbors few genetic alterations other than the initiating RB1 inactivation and corresponds to differentiated tumors expressing mature cone markers. By contrast, subtype 2 tumors harbor frequent recurrent genetic alterations including MYCN-amplification. They express markers of less differentiated cone together with neuronal/ganglion cell markers with marked inter- and intra-tumor heterogeneity. The cone dedifferentiation in subtype 2 is associated with stemness features including low immune and interferon response, E2F and MYC/MYCN activation and a higher propensity for metastasis. The recognition of these two subtypes, one maintaining a cone-differentiated state, and the other, more aggressive, associated with cone dedifferentiation and expression of neuronal markers, opens up important biological and clinical perspectives for retinoblastomas.